{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:29:54Z","timestamp":1789471794697,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dysregulation of microRNAs (miRNAs) is involved in the pathogenesis of neurodegenerative diseases, including Alzheimer\u2019s disease (AD). Hitherto, sample sizes from differential miRNA expression studies in AD are exceedingly small aggravating any biological inference. To overcome this limitation, we investigated six candidate miRNAs in a large collection of brain samples. Brain tissue was derived from superior temporal gyrus (STG) and entorhinal cortex (EC) from 99 AD patients and 91 controls. MiRNA expression was examined by qPCR (STG) or small RNA sequencing (EC). Brain region-dependent differential miRNA expression was investigated in a transgenic AD mouse model using qPCR and FISH. Total RNA sequencing was used to assess differential expression of miRNA target genes. MiR-129-5p, miR-132-5p, and miR-138-5p were significantly downregulated in AD vs. controls both in STG and EC, while miR-125b-5p and miR-501-3p showed no evidence for differential expression in this dataset. In addition, miR-195-5p was significantly upregulated in EC but not STG in AD patients. The brain region-specific pattern of miR-195-5p expression was corroborated in vivo in transgenic AD mice. Total RNA sequencing identified several novel and functionally interesting target genes of these miRNAs involved in synaptic transmission (\n                    <jats:italic>GABRB1<\/jats:italic>\n                    ), the immune-system response (\n                    <jats:italic>HCFC2<\/jats:italic>\n                    ) or AD-associated differential methylation (\n                    <jats:italic>SLC16A3<\/jats:italic>\n                    ). Using two different methods (qPCR and small RNA-seq) in two separate brain regions in 190 individuals we more than doubled the available sample size for most miRNAs tested. Differential gene expression analyses confirm the likely involvement of miR-129-5p, miR-132-5p, miR-138-5p, and miR-195-5p in AD pathogenesis and highlight several novel potentially relevant target mRNAs.\n                  <\/jats:p>","DOI":"10.1038\/s41398-022-02108-4","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T01:02:41Z","timestamp":1661821361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Differential microRNA expression analyses across two brain regions in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Valerija","family":"Dobricic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-7792","authenticated-orcid":false,"given":"Marcel","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Shuang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Fu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Franzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-9229","authenticated-orcid":false,"given":"Ling-Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Parkkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Lill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-124X","authenticated-orcid":false,"given":"Lars","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"2108_CR1","doi-asserted-by":"crossref","unstructured":"Karlsson IK, Escott-Price V, Gatz M, Hardy J, Pedersen NL, Shoai M, et al. Measuring heritable contributions to Alzheimer\u2019s disease: polygenic risk score analysis with twins. Brain Commun. 2022;4:fcab308.","DOI":"10.1093\/braincomms\/fcab308"},{"key":"2108_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","volume":"69","author":"TS Wingo","year":"2012","unstructured":"Wingo TS, Lah JJ, Levey AI, Cutler DJ. Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol. 2012;69:59\u201364.","journal-title":"Arch Neurol"},{"key":"2108_CR3","doi-asserted-by":"crossref","unstructured":"Smith RG, Pishva E, Shireby G, Smith AR, Roubroeks JAY, Hannon E, et al. A meta-analysis of epigenome-wide association studies in Alzheimer\u2019s disease highlights novel differentially methylated loci across cortex. Nat Commun. 2021;12:3517.","DOI":"10.1038\/s41467-021-23243-4"},{"key":"2108_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","volume":"32","author":"SS H\u00e9bert","year":"2009","unstructured":"H\u00e9bert SS, De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009;32:199\u2013206.","journal-title":"Trends Neurosci"},{"key":"2108_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20163979","volume":"20","author":"S Silvestro","year":"2019","unstructured":"Silvestro S, Bramanti P, Mazzon E. Role of miRNAs in alzheimer\u2019s disease and possible fields of application. Int J Mol Sci. 2019;20:1\u201326.","journal-title":"Int J Mol Sci"},{"key":"2108_CR6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP. Metazoan MicroRNAs. Cell 2018;173:20\u201351.","journal-title":"Cell"},{"key":"2108_CR7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010;466:835\u201340.","journal-title":"Nature"},{"key":"2108_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.00665","volume":"10","author":"F Angelucci","year":"2019","unstructured":"Angelucci F, Cechova K, Valis M, Kuca K, Zhang B, Hort J. MicroRNAs in Alzheimer\u2019s disease: diagnostic markers or therapeutic agents? Front Pharm. 2019;10:1\u20139.","journal-title":"Front Pharm"},{"key":"2108_CR9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.gpb.2019.09.004","volume":"17","author":"N Ludwig","year":"2019","unstructured":"Ludwig N, Fehlmann T, Kern F, Gogol M, Maetzler W, Deutscher S. et al. Machine learning to detect Alzheimer\u2019s disease from circulating non-coding RNAs. Genomics Proteom. Bioinform 2019;17:430\u201340.","journal-title":"Genomics Proteom. Bioinform"},{"key":"2108_CR10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jalz.2019.06.4952","volume":"15","author":"P Takousis","year":"2019","unstructured":"Takousis P, Sadlon A, Schulz J, Wohlers I, Dobricic V, Middleton L, et al. Differential expression of microRNAs in Alzheimer\u2019s disease brain, blood, and cerebrospinal fluid. Alzheimer\u2019s Dement. 2019;15:1468\u201377.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2108_CR11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","volume":"55","author":"R Clarke","year":"1998","unstructured":"Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449\u201355.","journal-title":"Arch Neurol"},{"key":"2108_CR12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1192\/bjp.149.6.698","volume":"149","author":"M Roth","year":"1986","unstructured":"Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S. et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698\u2013709.","journal-title":"Br J Psychiatry"},{"key":"2108_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"2108_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2012;8:1\u201313.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2108_CR15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"S Mirra","year":"1991","unstructured":"Mirra S, Heyman A, McKeel D SMS, Crain B, Brownlee L, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 1991;41:479\u201386.","journal-title":"Neurology"},{"key":"2108_CR16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ana.25490","volume":"85","author":"J Schulz","year":"2019","unstructured":"Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, R\u00fccker G, et al. Meta-analyses identify differentially expressed micrornas in Parkinson\u2019s disease. Ann Neurol. 2019;85:835\u201351.","journal-title":"Ann Neurol"},{"key":"2108_CR17","first-page":"895","volume":"1","author":"M Dodt","year":"2012","unstructured":"Dodt M, Roehr JT, Ahmed R, Dieterich C. FLEXBAR-flexible barcode and adapter processing for next-generation sequencing platforms. Biology (Basel). 2012;1:895\u2013905.","journal-title":"Biology (Basel)"},{"key":"2108_CR18","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1093\/bioinformatics\/btx330","volume":"33","author":"JT Roehr","year":"2017","unstructured":"Roehr JT, Dieterich C, Reinert K. Flexbar 3.0 - SIMD and multicore parallelization. Bioinformatics 2017;33:2941\u20132.","journal-title":"Bioinformatics"},{"key":"2108_CR19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:140\u20134.","journal-title":"Nucleic Acids Res"},{"key":"2108_CR20","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. MiRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47:D155\u201362.","journal-title":"Nucleic Acids Res"},{"key":"2108_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedl\u00e4nder","year":"2012","unstructured":"Friedl\u00e4nder MR, MacKowiak SD, Li N, Chen W, Rajewsky N. MiRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012;40:37\u201352.","journal-title":"Nucleic Acids Res"},{"key":"2108_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2014-15-1-r1","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"key":"2108_CR23","doi-asserted-by":"crossref","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","volume":"49","author":"KL Howe","year":"2021","unstructured":"Howe KL, Achuthan P, Allen J, Allen J, Alvarez-Jarreta J, Amode MR, et al. Ensembl 2021. Nucleic Acids Res. 2021;49:D884\u201391.","journal-title":"Nucleic Acids Res"},{"key":"2108_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34:525\u20137.","journal-title":"Nat Biotechnol"},{"key":"2108_CR25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","volume":"14","author":"H Pimentel","year":"2017","unstructured":"Pimentel H, Bray NL, Puente S, Melsted P, Pachter L. Differential analysis of RNA-seq incorporating quantification uncertainty. Nat Methods. 2017;14:687\u201390.","journal-title":"Nat Methods"},{"key":"2108_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of microRNA targeting efficacy. Science 2019;366:1\u201320.","journal-title":"Science"},{"key":"2108_CR27","doi-asserted-by":"crossref","unstructured":"Acquarone E, Argyrousi EK, Van Den Berg M, Gulisano W, F\u00e0 M, Staniszewski A, et al. Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade. Mol Neurodegener. 2019;14:26.","DOI":"10.1186\/s13024-019-0326-4"},{"key":"2108_CR28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuron.2016.12.023","volume":"93","author":"H Fu","year":"2017","unstructured":"Fu H, Rodriguez GA, Herman M, Emrani S, Nahmani E, Barrett G, et al. Tau pathology induces excitatory neuron loss, grid cell dysfunction, and spatial memory deficits reminiscent of early Alzheimer\u2019s disease. Neuron 2017;93:533\u201341.e5.","journal-title":"Neuron"},{"key":"2108_CR29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature17172","volume":"531","author":"DS Roy","year":"2016","unstructured":"Roy DS, Arons A, Mitchell TI, Pignatelli M, Ryan TJ, Tonegawa S. Memory retrieval by activating engram cells in mouse models of early Alzheimer\u2019s disease. Nature 2016;531:508\u201312.","journal-title":"Nature"},{"key":"2108_CR30","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/emmm.201201974","volume":"5","author":"P Lau","year":"2013","unstructured":"Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S, et al. Alteration of the microRNA network during the progression of Alzheimer\u2019s disease. EMBO Mol Med. 2013;5:1613\u201334.","journal-title":"EMBO Mol Med"},{"key":"2108_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nn.3631","volume":"17","author":"MA Yassa","year":"2014","unstructured":"Yassa MA. Ground zero in Alzheimer\u2019s disease. Nat Neurosci. 2014;17:146\u20137.","journal-title":"Nat Neurosci"},{"key":"2108_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0191-y","volume":"12","author":"E Patrick","year":"2017","unstructured":"Patrick E, Rajagopal S, Wong HKA, McCabe C, Xu J, Tang A, et al. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer\u2019s disease. Mol Neurodegener. 2017;12:1\u201313.","journal-title":"Mol Neurodegener"},{"key":"2108_CR33","doi-asserted-by":"crossref","unstructured":"Li QS, Cai D. Integrated miRNA-Seq and mRNA-Seq study to identify miRNAs associated with Alzheimer\u2019s disease using post-mortem brain tissue samples. Front Neurosci. 2021;15:620899.","DOI":"10.3389\/fnins.2021.620899"},{"key":"2108_CR34","unstructured":"Homo sapiens solute carrier family 16 member 3 (SLC16A3), transcript v - Nucleotide - NCBI [Internet]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/1890259789."},{"key":"2108_CR35","doi-asserted-by":"crossref","unstructured":"Li QS, Sun Y, Wang T. Epigenome-wide association study of Alzheimer\u2019s disease replicates 22 differentially methylated positions and 30 differentially methylated regions. Clin Epigenetics. 2020;12:149.","DOI":"10.1186\/s13148-020-00944-z"},{"key":"2108_CR36","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/alz.12310","volume":"17","author":"ER Saito","year":"2021","unstructured":"Saito ER, Miller JB, Harari O, Cruchaga C, Mihindukulasuriya KA, Kauwe JSK. et al. Alzheimer\u2019s disease alters oligodendrocytic glycolytic and ketolytic gene expression. Alzheimers Dement. 2021;17:1474\u201386.","journal-title":"Alzheimers Dement"},{"key":"2108_CR37","unstructured":"Homo sapiens host cell factor C2 (HCFC2), mRNA - Nucleotide - NCBI [Internet]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/NM_013320."},{"key":"2108_CR38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7150\/ijms.66422","volume":"19","author":"C Liu","year":"2022","unstructured":"Liu C, Zhang X, Chai H, Xu S, Liu Q, Luo Y. et al. Identification of immune cells and key genes associated with Alzheimer\u2019s disease. Int J Med Sci. 2022;19:112\u201325.","journal-title":"Int J Med Sci"},{"key":"2108_CR39","unstructured":"Homo sapiens gamma-aminobutyric acid type A receptor subunit beta1 (GA - Nucleotide - NCBI. Available from: https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/NM_000812."},{"key":"2108_CR40","doi-asserted-by":"crossref","unstructured":"Rice HC, De Malmazet D, Schreurs A, Frere S, Van Molle I, Volkov AN, et al. Secreted amyloid-\u03b2 precursor protein functions as a GABA B R1a ligand to modulate synaptic transmission. Science 2019;363:eaao4827.","DOI":"10.1126\/science.aao4827"},{"key":"2108_CR41","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1373\/clinchem.2009.141580","volume":"56","author":"M Jung","year":"2010","unstructured":"Jung M, Schaefer A, Steiner I, Kempkensteffen C, Stephan C, Erbersdobler A, et al. Robust MicroRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem. 2010;56:998\u20131006.","journal-title":"Clin Chem"},{"key":"2108_CR42","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45:1452\u20138.","journal-title":"Nat Genet"},{"key":"2108_CR43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"I Jansen","year":"2019","unstructured":"Jansen I, Savage J, Watanabe K, Bryois J, Williams D, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"2108_CR44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330.","journal-title":"Nat Genet"},{"key":"2108_CR45","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/bpa.12882","volume":"30","author":"L Bertram","year":"2020","unstructured":"Bertram L, Tanzi RE. Genomic mechanisms in Alzheimer\u2019s disease. Brain Pathol. 2020;30:966\u201377.","journal-title":"Brain Pathol"},{"key":"2108_CR46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen I, Andrade V, Moreno-grau S. New insights on the genetic etiology of Alzheimer\u2019s and related dementia. Nat Genet. 2022;54:412\u201336.","journal-title":"Nat Genet"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02108-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T03:42:15Z","timestamp":1700970135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2108"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02108-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.31.446406","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}